Jonathan S Weissman Selected Research

Jonathan S Weissman Research Topics

Disease

17	Neoplasms (Cancer) 12/2022 - 05/2010
7	Infections 10/2023 - 01/2004
3	Leukemia 11/2023 - 11/2013
3	Starvation 01/2021 - 02/2011
2	Rhabdomyosarcoma 12/2022 - 01/2016
2	COVID-19 01/2022 - 09/2021
2	Breast Neoplasms (Breast Cancer) 07/2018 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 11/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2015 - 02/2002
2	Noncommunicable Diseases 09/2007 - 01/2004
1	Adenocarcinoma of Lung 01/2022
1	Microsatellite Instability 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Glioma (Gliomas) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Osteoporosis 10/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2017
1	Multiple Myeloma 09/2015
1	Cholera 10/2014
1	Herpesviridae Infections (Herpesvirus Infection) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2012
1	Neoplasm Metastasis (Metastasis) 02/2012
1	Asthma (Bronchial Asthma) 02/2010
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2004

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2004
4	Amyloid (Amyloid Fibrils)IBA 01/2006 - 02/2002
3	InterferonsIBA 10/2023 - 09/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2021
3	PrionsIBA 01/2006 - 02/2002
2	Cell Surface ReceptorsIBA 01/2022 - 09/2021
2	AntigensIBA 01/2021 - 01/2018
2	Long Noncoding RNAIBA 01/2020 - 01/2018
2	ON 01910IBA 01/2020 - 10/2017
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2018 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 02/2012 - 02/2011
2	Protein AggregatesIBA 01/2004 - 02/2002
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2022
1	Adenosine Triphosphatases (ATPase)IBA 12/2022
1	Cytotoxins (Cytolysins)IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 10/2021
1	SurvivinIBA 01/2021
1	SulfurIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Ligases (Synthetase)IBA 01/2019
1	PalmitatesIBA 01/2019
1	UbiquitinIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Cycloheximide (Cicloheximide)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Diphosphonates (Bisphosphonates)IBA 10/2018
1	NitrogenIBA 10/2018
1	NucleotidesIBA 07/2018
1	benzothiazoleIBA 07/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	AntibodiesIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	TubulinIBA 10/2017
1	5' Untranslated Regions (5' UTR)IBA 01/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	CB-5083IBA 11/2015
1	Ubiquitinated ProteinsIBA 11/2015
1	ATPases Associated with Diverse Cellular ActivitiesIBA 11/2015
1	Proteasome InhibitorsIBA 09/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2015
1	carfilzomibIBA 09/2015
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 04/2015
1	Molecular Chaperones (Chaperone, Molecular)IBA 03/2015
1	Diphtheria ToxinIBA 10/2014
1	Peptides (Polypeptides)IBA 09/2014
1	ProteomeIBA 01/2014
1	STF-118804IBA 11/2013
1	sapanisertibIBA 02/2012
1	TOR Serine-Threonine KinasesIBA 02/2012
1	Phosphotransferases (Kinase)IBA 02/2012
1	Phosphates (Orthophosphate)IBA 02/2011
1	SphingolipidsIBA 02/2010
1	Prion ProteinsIBA 04/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2023 - 01/2016
2	Transcutaneous Electric Nerve Stimulation (TENS) 01/2022 - 01/2021
2	Therapeutics 01/2020 - 01/2016
1	Radiotherapy 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017